Abstract
•Nonsteroidal anti-inflammatory drugs (NSAIDs) increase the risk of myocardial infarction and stroke •The FDA revised the labeling explaining the cardiovascular risks associated with NSAIDs •Risks and benefits should be weighed for patients, with or without heart disease or risk factors for heart disease, when deciding to recommend a NSAID treatment course Both authors are affiliated with The Mount Sinai Hospital in New York, NY. Jason Babby, PharmD, BCPS, is a drug information clinical pharmacist. He can be reached at . Archna Lall, PharmD, BCPS, CGP, is a pharmacist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
